Yunyang Song
Yunyang Song has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Fanghui Wu
State Key Laboratory of NBC Protection for Civilian, Beijing, 102205, China
3 shared publications - Hui Jiang
State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China
2 shared publications - Yanli Liu
State Key Laboratory of NBC Protection for Civilian, Beijing, 102205, China
2 shared publications - Yifeng Yin
State Key Laboratory of NBC Protection for Civilian, Beijing, 102205, China
2 shared publications - Zitong Zhao
State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China
2 shared publications Chu Wang
State Key Laboratory of NBC Protection for Civilian, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 10 (3) , 973-982
High-yield production and characterization of functional Kir2.1 ion channel using E. coli cell-free protein synthesis system
A family of inwardly-rectifying potassium (Kir) channels plays a key role in the regulation of cellular potassium (K+) balance, affecting muscle, nerve and immune function. Kir channels are comprised of either homologous or heterologous tetramer of Kir subunits, each of which contains two-transmembrane domains. The challenges associated with the precise biophysical characterization of Kir channels have limited our understanding of this important class of molecules. Moreover, the complex multi-transmembrane domains inherent to Kir channels present significant obstacles in producing sufficient quantities for accurate characterization, further constraining our knowledge about these channels. In this study, we selected Kir2.1 as a model molecule and utilized an Escherichia coli cell-free protein expression system (CFPS) to synthesize Kir2.1 in the presence of peptide surfactant A6K, which aids in promoting the soluble production, achieving α-helical conformations, and stabilizing membrane proteins (MPs). Ni-NTA affinity chromatography column was employed to purify Kir2.1, achieving a yield of approximately 1.5 mg/mL. Circular dichroism spectroscopy (CD) measurements confirmed that the purified Kir2.1 exhibited typical α-helix structures. Microscale thermophoresis (MST) assays demonstrated the binding capability of Kir2.1 with Hydrocinnamic Acid and ML133 hydrochloride, Kir2 channel selection inhibitory. Recombinant Kir2.1-liposomes exhibited specific channel activity to K+ using the voltage-sensitive fluorescent dye Oxonol VI to monitor the concentration gradient-driven potassium influx. This work contributes to enhancing both the efficiency of preparation, characterization and drug high-throughput screening of ion channels.
- 1 September 2025
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 10 (3) , 973-982
Open AccessHigh-yield production and characterization of functional Kir2.1 ion channel using E. coli cell-free protein synthesis system
A family of inwardly-rectifying potassium (Kir) channels plays a key role in the regulation of cellular potassium (K+) balance, affecting muscle, nerve and immune function. Kir channels are comprised of either homologous or heterologous tetramer of Kir subunits, each of which contains two-transmembrane domains. The challenges associated with the precise biophysical characterization of Kir channels have limited our understanding of this important class of molecules. Moreover, the complex multi-transmembrane domains inherent to Kir channels present significant obstacles in producing sufficient quantities for accurate characterization, further constraining our knowledge about these channels. In this study, we selected Kir2.1 as a model molecule and utilized an Escherichia coli cell-free protein expression system (CFPS) to synthesize Kir2.1 in the presence of peptide surfactant A6K, which aids in promoting the soluble production, achieving α-helical conformations, and stabilizing membrane proteins (MPs). Ni-NTA affinity chromatography column was employed to purify Kir2.1, achieving a yield of approximately 1.5 mg/mL. Circular dichroism spectroscopy (CD) measurements confirmed that the purified Kir2.1 exhibited typical α-helix structures. Microscale thermophoresis (MST) assays demonstrated the binding capability of Kir2.1 with Hydrocinnamic Acid and ML133 hydrochloride, Kir2 channel selection inhibitory. Recombinant Kir2.1-liposomes exhibited specific channel activity to K+ using the voltage-sensitive fluorescent dye Oxonol VI to monitor the concentration gradient-driven potassium influx. This work contributes to enhancing both the efficiency of preparation, characterization and drug high-throughput screening of ion channels.
- Open Access
- 23 July 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1596813
Synergistic effects of combined hypnotic drugs on sleep in mice
Study objectives: To investigate the interaction and potential mechanisms of the combined administration of dexmedetomidine (DMED) and eszopiclone (ESZ) on sleep in mice.Methods: The effects of DMED, ESZ and the combination of the two drugs on the sleep status of mice were investigated by using the loss of righting reflex (LORR) as an indicator, the sleep-related parameters were recorded, and the interactions of the combination of DMED and ESZ on sleep were determined by isobolographic analysis. The effects of DMED and ESZ on sleep structure, the regulation of c-Fos protein expression in the ventrolateral preoptic area (VLPO) and the tuberomammillary nucleus (TMN) and the regulation of neurotransmitter levels were further investigated by combining electroencephalogram/electromyogram (EEG/EMG) sleep phase analysis, c-Fos immunofluorescence, and neurotransmitter content measurements in the brain.Results: Isobolographic analysis demonstrated that the combination of DMED and ESZ had a synergistic effect on sleep in mice. The duration of non-rapid eye movement (NREM) sleep was significantly prolonged; the number of c-Fos positive neurons increased in the VLPO and decreased in the TMN; the levels of excitatory neurotransmitters were reduced, while the levels of inhibitory neurotransmitters were elevated.Conclusion: This study reveals that the combination of DMED and ESZ exerts a synergistic effect on sleep in mice. The underlying mechanism may involve the prolongation of NREM sleep, modulation of neuronal activity in the brain regions of VLPO and TMN, as well as alteration in the levels of brain neurotransmitters.
- 23 July 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1596813
Open AccessSynergistic effects of combined hypnotic drugs on sleep in mice
Study objectives: To investigate the interaction and potential mechanisms of the combined administration of dexmedetomidine (DMED) and eszopiclone (ESZ) on sleep in mice.Methods: The effects of DMED, ESZ and the combination of the two drugs on the sleep status of mice were investigated by using the loss of righting reflex (LORR) as an indicator, the sleep-related parameters were recorded, and the interactions of the combination of DMED and ESZ on sleep were determined by isobolographic analysis. The effects of DMED and ESZ on sleep structure, the regulation of c-Fos protein expression in the ventrolateral preoptic area (VLPO) and the tuberomammillary nucleus (TMN) and the regulation of neurotransmitter levels were further investigated by combining electroencephalogram/electromyogram (EEG/EMG) sleep phase analysis, c-Fos immunofluorescence, and neurotransmitter content measurements in the brain.Results: Isobolographic analysis demonstrated that the combination of DMED and ESZ had a synergistic effect on sleep in mice. The duration of non-rapid eye movement (NREM) sleep was significantly prolonged; the number of c-Fos positive neurons increased in the VLPO and decreased in the TMN; the levels of excitatory neurotransmitters were reduced, while the levels of inhibitory neurotransmitters were elevated.Conclusion: This study reveals that the combination of DMED and ESZ exerts a synergistic effect on sleep in mice. The underlying mechanism may involve the prolongation of NREM sleep, modulation of neuronal activity in the brain regions of VLPO and TMN, as well as alteration in the levels of brain neurotransmitters.
- Open Access
- 25 July 2023
- Published by MDPI AG in Marine Drugs
- Vol. 21 (8) , 421
Usage of Cell-Free Protein Synthesis in Post-Translational Modification of μ-Conopeptide PIIIA
The post-translational modifications of conopeptides are the most complicated modifications to date and are well-known and closely related to the activity of conopeptides. The hydroxylation of proline in conopeptides affects folding, structure, and biological activity, and prolyl 4 hydroxylase has been characterized in Conus literatus. However, the hydroxylation machinery of proline in conopeptides is still unclear. In order to address the hydroxylation mechanism of proline in μ-PIIIA, three recombinant plasmids encoding different hybrid precursors of μ-PIIIA were constructed and crossly combined with protein disulfide isomerase, prolyl 4 hydroxylase, and glutaminyl cyclase in a continuous exchange cell-free protein system. The findings showed that prolyl 4 hydroxylase might recognize the propeptide of μ-PIIIA to achieve the hydroxylation of proline, while the cyclization of glutamate was also formed. Additionally, in Escherichia coli, the co-expression plasmid encoding prolyl 4 hydroxylase and the precursor of μ-PIIIA containing pro and mature regions were used to validate the continuous exchange cell-free protein system. Surprisingly, in addition to the two hydroxyproline residues and one pyroglutamyl residue, three disulfide bridges were formed using Trx as a fusion tag, and the yield of the fusion peptide was approximately 20 mg/L. The results of electrophysiology analysis indicated that the recombinant μ-PIIIA without C-terminal amidate inhibited the current of hNaV1.4 with a 939 nM IC50. Our work solved the issue that it was challenging to quickly generate post-translationally modified conopeptides in vitro. This is the first study to demonstrate that prolyl 4 hydroxylase catalyzes the proline hydroxylation through recognition in the propeptide of μ-PIIIA, and it will provide a new way for synthesizing multi-modified conopeptides with pharmacological activity.
- 25 July 2023
- Published by MDPI AG in Marine Drugs
- Vol. 21 (8) , 421
Open AccessUsage of Cell-Free Protein Synthesis in Post-Translational Modification of μ-Conopeptide PIIIA
The post-translational modifications of conopeptides are the most complicated modifications to date and are well-known and closely related to the activity of conopeptides. The hydroxylation of proline in conopeptides affects folding, structure, and biological activity, and prolyl 4 hydroxylase has been characterized in Conus literatus. However, the hydroxylation machinery of proline in conopeptides is still unclear. In order to address the hydroxylation mechanism of proline in μ-PIIIA, three recombinant plasmids encoding different hybrid precursors of μ-PIIIA were constructed and crossly combined with protein disulfide isomerase, prolyl 4 hydroxylase, and glutaminyl cyclase in a continuous exchange cell-free protein system. The findings showed that prolyl 4 hydroxylase might recognize the propeptide of μ-PIIIA to achieve the hydroxylation of proline, while the cyclization of glutamate was also formed. Additionally, in Escherichia coli, the co-expression plasmid encoding prolyl 4 hydroxylase and the precursor of μ-PIIIA containing pro and mature regions were used to validate the continuous exchange cell-free protein system. Surprisingly, in addition to the two hydroxyproline residues and one pyroglutamyl residue, three disulfide bridges were formed using Trx as a fusion tag, and the yield of the fusion peptide was approximately 20 mg/L. The results of electrophysiology analysis indicated that the recombinant μ-PIIIA without C-terminal amidate inhibited the current of hNaV1.4 with a 939 nM IC50. Our work solved the issue that it was challenging to quickly generate post-translationally modified conopeptides in vitro. This is the first study to demonstrate that prolyl 4 hydroxylase catalyzes the proline hydroxylation through recognition in the propeptide of μ-PIIIA, and it will provide a new way for synthesizing multi-modified conopeptides with pharmacological activity.
- Open Access
- 12 August 2020
- Published by MDPI AG in Marine Drugs
- Vol. 18 (8) , 422
α-Conotoxin as Potential to α7-nAChR Recombinant Expressed in Escherichia coli
α7 nicotinic acetylcholine receptors (nAChR) is an important nicotinic acetylcholine receptors subtype and closely associated with cognitive disorders, such as Alzheimer’s and schizophrenia disease. The mutant ArIB (V11L, V16A) of α-conotoxin ArIB with 17-amino acid residues specifically targets α7 nAChR with no obvious effect on other nAChR subtypes. In the study, the synthetic gene encoding mature peptide of ArIB and mutant ArIB (V11L, V16A) carried a fusion protein Trx and 6 × His-tag was separately inserted in pET-32a (+) vector and transformed into Escherichia coli strain BL21(DE3) pLysS for expression. The expressions of Trx-ArIB-His6 and Trx-ArIB (V11L, V16A)-His6 were soluble in Escherichia coli, which were purified by Ni-NTA affinity chromatography column and cleaved by enterokinase to release rArIB and rArIB (V11L, V16A). Then, rArIB and rArIB (V11L, V16A) were purified by high-performance liquid chromatography (HPLC) and identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Bioactivity of rArIB and rArIB (V11L, V16A) was assessed by two-electrode voltage-clamp electrophysiology in Xenopus laevis oocytes expressing human nAChR subtypes. The results indicated that the yield of the fusion proteins was approximately 50 mg/L and rArIB (V11L, V16A) antagonized the α7 nAChR subtype selectively with 8-nM IC50. In summary, this study provides an efficient method to biosynthesize α-conotoxin ArIB and rArIB (V11L, V16A) in Escherichia coli, which could be economical to obtain massively bioactive disulfide-rich polypeptides at fast speed.
- 12 August 2020
- Published by MDPI AG in Marine Drugs
- Vol. 18 (8) , 422
Open Accessα-Conotoxin as Potential to α7-nAChR Recombinant Expressed in Escherichia coli
α7 nicotinic acetylcholine receptors (nAChR) is an important nicotinic acetylcholine receptors subtype and closely associated with cognitive disorders, such as Alzheimer’s and schizophrenia disease. The mutant ArIB (V11L, V16A) of α-conotoxin ArIB with 17-amino acid residues specifically targets α7 nAChR with no obvious effect on other nAChR subtypes. In the study, the synthetic gene encoding mature peptide of ArIB and mutant ArIB (V11L, V16A) carried a fusion protein Trx and 6 × His-tag was separately inserted in pET-32a (+) vector and transformed into Escherichia coli strain BL21(DE3) pLysS for expression. The expressions of Trx-ArIB-His6 and Trx-ArIB (V11L, V16A)-His6 were soluble in Escherichia coli, which were purified by Ni-NTA affinity chromatography column and cleaved by enterokinase to release rArIB and rArIB (V11L, V16A). Then, rArIB and rArIB (V11L, V16A) were purified by high-performance liquid chromatography (HPLC) and identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Bioactivity of rArIB and rArIB (V11L, V16A) was assessed by two-electrode voltage-clamp electrophysiology in Xenopus laevis oocytes expressing human nAChR subtypes. The results indicated that the yield of the fusion proteins was approximately 50 mg/L and rArIB (V11L, V16A) antagonized the α7 nAChR subtype selectively with 8-nM IC50. In summary, this study provides an efficient method to biosynthesize α-conotoxin ArIB and rArIB (V11L, V16A) in Escherichia coli, which could be economical to obtain massively bioactive disulfide-rich polypeptides at fast speed.